HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

D M Shin Selected Research

Antineoplastic Agents (Antineoplastics)

11/2001Phase II study of the antiangiogenesis agent thalidomide in recurrent or metastatic squamous cell carcinoma of the head and neck.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


D M Shin Research Topics

Disease

18Neoplasms (Cancer)
01/2017 - 02/2000
9Squamous Cell Carcinoma of Head and Neck
11/2008 - 02/2000
6Head and Neck Neoplasms (Head and Neck Cancer)
06/2001 - 08/2000
5Neoplasm Metastasis (Metastasis)
01/2017 - 07/2000
5Carcinogenesis
11/2008 - 07/2000
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2001 - 02/2000
2Fatigue
06/2001 - 04/2001
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
06/2001 - 07/2000
2Squamous Cell Neoplasms (Squamous Cell Cancer)
05/2001 - 02/2001
1Thyroid Neoplasms (Thyroid Cancer)
03/2013
1Thrombocytopenia (Thrombopenia)
03/2013
1Neutropenia
03/2013
1Prostatic Neoplasms (Prostate Cancer)
12/2011
1Hypopharyngeal Neoplasms
05/2009
1Multiple Myeloma
11/2001
1Residual Neoplasm
11/2001
1Hypertriglyceridemia
06/2001
1Genomic Instability
06/2001
1Pancreatitis
05/2001
1Pleural Effusion (Pleural Effusions)
05/2001
1Renal Insufficiency (Renal Failure)
05/2001
1Anorexia
04/2001
1Peripheral Nervous System Diseases (PNS Diseases)
04/2001
1Tics (Tic)
04/2001
1Vomiting
04/2001
1Fever (Fevers)
04/2001
1Hearing Loss (Hearing Impairment)
02/2001
1Hypocalcemia
02/2001
1Mesothelioma
08/2000
1Malignant Mesothelioma
08/2000
1Hyperplasia
07/2000
1Lung Neoplasms (Lung Cancer)
04/2000

Drug/Important Bio-Agent (IBA)

7Proteins (Proteins, Gene)FDA Link
10/2016 - 04/2000
7Cisplatin (Platino)FDA LinkGeneric
06/2001 - 02/2000
3Biological ProductsIBA
06/2001 - 04/2001
3Paclitaxel (Taxol)FDA LinkGeneric
06/2001 - 02/2000
3Fluorouracil (Carac)FDA LinkGeneric
06/2001 - 08/2000
2taxaneIBA
06/2001 - 08/2000
2Docetaxel (Taxotere)FDA Link
06/2001 - 02/2001
2RetinoidsIBA
05/2001 - 05/2000
2ErbB Receptors (EGF Receptor)IBA
05/2001 - 05/2001
2CarcinogensIBA
04/2001 - 11/2000
2IfosfamideFDA LinkGeneric
04/2001 - 02/2000
1Lactate Dehydrogenase 5IBA
01/2017
1Acetylcysteine (Siran)FDA LinkGeneric
01/2017
1AntioxidantsIBA
01/2017
1EnzymesIBA
01/2017
1RNA (Ribonucleic Acid)IBA
01/2017
1Reactive Oxygen Species (Oxygen Radicals)IBA
01/2017
1Pyruvic Acid (Pyruvate)IBA
01/2017
1Lactic Acid (Lactate)FDA LinkGeneric
01/2017
190-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 90 kDa)IBA
10/2016
1Serine (L-Serine)FDA Link
10/2016
1StathminIBA
10/2016
1Bortezomib (Velcade)FDA Link
03/2013
1Sunitinib (Sutent)FDA Link
03/2013
1sparfosic acid (PALA)IBA
02/2013
1Caveolin 1IBA
11/2008
1IntegrinsIBA
11/2008
1Integrin beta1IBA
11/2008
1Complementary DNA (cDNA)IBA
11/2008
1Thalidomide (Thalomid)FDA Link
11/2001
1Cytotoxins (Cytolysins)IBA
11/2001
1Antineoplastic Agents (Antineoplastics)IBA
11/2001
1Cyclin D1IBA
10/2001
1Interferon-alpha (Interferon Alfa)IBA
06/2001
1alpha-TocopherolFDA Link
06/2001
1Isotretinoin (Accutane)FDA LinkGeneric
06/2001
1Methotrexate (Mexate)FDA LinkGeneric
06/2001
1Taxoids (Taxanes)IBA
06/2001
1Pharmaceutical PreparationsIBA
05/2001
1LigandsIBA
05/2001
1Bexarotene (LGD1069)FDA Link
05/2001
1Vinorelbine (Navelbine)FDA LinkGeneric
05/2001
1Triglycerides (Triacylglycerol)IBA
05/2001
1Retinoid X Receptors (Retinoid X Receptor)IBA
05/2001
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
05/2001
1Cetuximab (Erbitux)FDA Link
05/2001
1Cell Surface ReceptorsIBA
05/2001
1Growth Factor ReceptorsIBA
05/2001
1Anti-Bacterial Agents (Antibiotics)IBA
04/2001
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
04/2001
1Carboplatin (JM8)FDA LinkGeneric
04/2001
1TeaIBA
03/2001
1liposomal doxorubicin (Doxil)FDA Link
08/2000
1ParaffinIBA
07/2000
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
07/2000
1Biomarkers (Surrogate Marker)IBA
05/2000
1retinoic acid receptor betaIBA
05/2000
1Peptides (Polypeptides)IBA
04/2000
1EpitopesIBA
04/2000
1AntigensIBA
04/2000

Therapy/Procedure

6Therapeutics
02/2013 - 05/2001
3Drug Therapy (Chemotherapy)
06/2001 - 02/2000
1Laryngectomy
05/2009
1Chemoprevention
10/2001
1TIP regimen
04/2001
1Induction Chemotherapy
02/2001
1Aftercare (After-Treatment)
05/2000
1Injections
04/2000